Can I Take Rhodiola With AndroGel?

What Is AndroGel and How Is It Used?

AndroGel delivers testosterone transdermally, restoring serum testosterone in men diagnosed with hypogonadism, defined clinically as two morning total testosterone readings below 300 ng/dL paired with symptoms. The FDA approved testosterone 1% gel (AndroGel) in 2000 and the higher-concentration 1.62% formulation in 2011 for this indication.

Pharmacokinetics of Transdermal Testosterone

After a 5 g dose of AndroGel 1%, approximately 10% of applied testosterone is absorbed through the skin over 24 hours, producing a steady-state serum testosterone in the normal male range (300 to 1,000 ng/dL) within 24 to 48 hours of daily use. Peak serum levels (Cmax) occur roughly 2 hours post-application [1]. The drug is metabolized hepatically via CYP3A4 to estradiol and dihydrotestosterone (DHT); CYP3A4 is the primary route of concern when assessing supplement interactions [2].

The Endocrine Society's 2018 clinical practice guideline states: "We recommend measuring testosterone levels 3 to 6 months after initiation of testosterone therapy to assess whether serum testosterone levels are in the mid-normal range" [3]. That monitoring window is your first safety checkpoint when adding any supplement, including rhodiola.

Approved Indications and Off-Label Use

AndroGel is approved only for confirmed hypogonadism in men. Prescribing it for age-related decline without a documented deficiency falls outside FDA-approved labeling [1]. Men who are prescribed AndroGel often seek adaptogens like rhodiola for energy and cognitive performance, which is why this combination appears frequently in clinical practice.

What Is Rhodiola Rosea?

Rhodiola rosea is a perennial flowering plant native to arctic and mountainous regions. It has been used in Scandinavian and Russian traditional medicine for physical stamina and stress resistance. The pharmacologically active constituents include rosavins (rosavin, rosin, rosarin) and salidroside (also called tyrosol glucoside) [4].

Mechanism of Action: Why It Matters for Drug Interactions

Rhodiola exerts adaptogenic effects through at least three pathways that are relevant when combined with testosterone therapy:

Monoamine modulation. Rhodiola inhibits monoamine oxidase A (MAO-A) and MAO-B in vitro, preventing breakdown of serotonin, dopamine, and norepinephrine [5]. This activity is weaker than pharmaceutical MAOIs but is pharmacodynamically additive with any agent affecting monoaminergic tone.

HPA-axis modulation. Salidroside reduces cortisol response to stress by downregulating stress-induced CRF (corticotropin-releasing factor) expression [6]. Because cortisol suppresses hypothalamic GnRH, any cortisol-lowering agent could theoretically amplify the gonadotropin axis. The clinical magnitude of this effect in men already on exogenous testosterone, whose HPG axis is already suppressed, is likely negligible.

CNS stimulation. Rhodiola increases CNS arousal, which is one reason it is taken for fatigue. A randomized, double-blind, crossover trial (N=56) published in the journal Phytomedicine found that a single 200 mg dose of SHR-5 extract improved mental fatigue scores significantly compared to placebo at 2 hours post-dose (P<0.01) [7]. This stimulant property is additive with testosterone's own modest CNS-activating effects.

Clinical Trials on Rhodiola Safety

The SHR-5 strain of Rhodiola rosea extract is the most studied preparation. A 2012 systematic review in Phytomedicine evaluated 11 randomized controlled trials and found the supplement well-tolerated at doses up to 680 mg/day for up to 12 weeks, with adverse events limited to dizziness, dry mouth, and agitation in a minority of participants [8]. No serious hepatotoxic, nephrotoxic, or cardiovascular events were reported in those trials.

A separate placebo-controlled trial (N=100) in men and women with burnout found that 400 mg/day of rhodiola extract for 12 weeks reduced cortisol awakening response by a statistically significant margin compared to placebo (P<0.05) [9]. This cortisol data is clinically useful context for men on AndroGel.

Pharmacokinetic Interaction: Does Rhodiola Affect Testosterone Levels?

This is the question most patients and clinicians ask first. The short answer: no strong pharmacokinetic (PK) interaction has been documented in controlled human studies between rhodiola and testosterone gel.

CYP3A4 Considerations

Testosterone is a known CYP3A4 substrate. Rhodiola rosea extract has demonstrated weak CYP3A4 inhibitory activity in vitro at high concentrations, but a 2019 study published in Drug Metabolism and Disposition found that at doses equivalent to standard human supplementation (200 to 600 mg/day), inhibition of CYP3A4-mediated metabolism was not clinically significant in human liver microsomes [10]. This suggests rhodiola is unlikely to meaningfully alter serum testosterone concentrations achieved with AndroGel.

P-glycoprotein and Transporter Effects

Salidroside has shown mild P-glycoprotein (P-gp) inhibitory activity in cell-based assays [11]. AndroGel delivers testosterone transdermally, bypassing intestinal P-gp entirely. This transporter interaction is therefore not a relevant clinical concern for this specific drug form.

Practical Implication

Routine testosterone monitoring at 4 to 6 weeks after adding rhodiola is still reasonable clinical practice, even if the PK interaction is minimal. A serum total testosterone drawn 2 hours after AndroGel application will reflect any unexpected shifts [3].

Pharmacodynamic Interaction: Where the Real Risk Lives

The more clinically meaningful concerns are pharmacodynamic, meaning both agents act on the same physiological systems and their effects can add together or oppose each other.

CNS Stimulation Overlap

Testosterone therapy at therapeutic serum levels (400 to 700 ng/dL) can improve mood, energy, and drive in hypogonadal men [12]. Rhodiola independently increases arousal and reduces mental fatigue [7]. In most men, this combination produces a welcome combination of energy and focus. In a subset, particularly those prone to anxiety or sleep disruption, the combined stimulant load may cause insomnia, elevated resting heart rate, or irritability.

A 2020 review in Nutrients identified "activation" adverse effects (agitation, insomnia, palpitations) as the most common dose-dependent side effects of rhodiola, occurring in roughly 5 to 10% of users in clinical trials [13]. Men starting AndroGel who are already experiencing testosterone-related energy shifts should introduce rhodiola at a low dose (200 mg/day) and titrate slowly.

MAOI-Like Pharmacodynamic Risk

Rhodiola's MAO-A and MAO-B inhibitory activity is the most important consideration for men taking additional medications alongside AndroGel. Although testosterone gel itself does not significantly affect monoamine metabolism, many men with hypogonadism are co-prescribed:

• SSRIs or SNRIs for depression secondary to low testosterone
• Stimulant medications (amphetamine salts, methylphenidate) for ADHD
• Bupropion, which itself has noradrenergic and dopaminergic activity

Adding a supplement with MAOI-like activity to any of these agents raises the theoretical risk of serotonin syndrome or cardiovascular overstimulation [5]. The FDA drug interaction guidance for MAOIs recommends a 14-day washout before combining them with serotonergic agents [14]. Rhodiola's inhibitory potency is far weaker than pharmaceutical MAOIs, but caution is warranted in any polypharmacy context.

Blood Pressure

Testosterone therapy is associated with a modest increase in hematocrit and, in some men, a small rise in blood pressure. Rhodiola at doses above 600 mg/day has shown mild vasopressor-like activity in some animal models [15]. Human clinical data at standard doses do not consistently replicate this, but men with pre-existing hypertension or borderline blood pressure should have a baseline reading before starting rhodiola alongside AndroGel.

Who Should Not Combine Rhodiola With AndroGel?

Most men on AndroGel can add rhodiola safely with clinician oversight. Certain subgroups face higher risk.

Higher-Risk Profiles

Men on SSRIs, SNRIs, or bupropion. The additive serotonergic and noradrenergic load from rhodiola's MAOI-like activity increases the theoretical risk of serotonin syndrome. This combination requires explicit prescriber review before proceeding [5].

Men on prescription MAOIs (phenelzine, tranylcypromine, selegiline). Avoid rhodiola entirely. The combined monoamine oxidase inhibition could be clinically significant [14].

Men with uncontrolled hypertension. Testosterone therapy alone carries a blood pressure signal. Adding a CNS-stimulating adaptogen without blood pressure control in place is not advisable.

Men on stimulant ADHD medications. Concurrent CNS stimulation from amphetamine salts plus rhodiola may produce tachycardia or anxiety at doses that would otherwise be tolerated.

Men with bipolar disorder. Rhodiola's stimulant and monoaminergic properties can destabilize mood in patients with bipolar spectrum illness, regardless of testosterone status [16].

Practical Guidance for Men Already Taking Both

If you are already taking rhodiola with AndroGel and have had no adverse effects, you do not necessarily need to stop. The interaction is not an emergency. These steps apply:

Step 1: Inform Your Prescriber

Tell your AndroGel prescriber you are taking rhodiola, including the dose, brand, and standardization (3% rosavins, 1% salidroside is the research-validated spec). Bring the bottle. This allows them to flag any interaction with co-prescribed medications.

Step 2: Time Your Doses Appropriately

Apply AndroGel in the morning after showering, as directed in the prescribing information [1]. Take rhodiola in the morning with or without food, at least 30 minutes before breakfast for best absorption, per study protocols used in clinical trials [7]. Avoid taking rhodiola in the late afternoon or evening because its stimulant properties may interfere with sleep onset, which is when the majority of daily testosterone secretion (in men not on therapy) occurs anyway.

Step 3: Monitor These Parameters

| Parameter | When to Check | Action Threshold | |---|---|---| | Serum total testosterone | 4-6 weeks after adding rhodiola | Below 300 or above 1,050 ng/dL warrants dose review | | Blood pressure | At next clinic visit | Systolic above 140 mmHg prompts medication reassessment | | Resting heart rate | Self-monitor for 2 weeks | Above 100 bpm at rest warrants discontinuing rhodiola | | Sleep quality | Daily self-report for 2 weeks | Onset latency above 45 min warrants rhodiola dose reduction | | Mood and anxiety | Clinician assessment | New agitation or anxiety warrants rhodiola discontinuation |

Step 4: Use a Research-Validated Product

Not all rhodiola products contain what the label states. A 2020 analysis published in Phytotherapy Research tested 28 commercial rhodiola supplements and found that 36% did not meet label claims for rosavins or salidroside content [17]. Choose a product standardized to 3% rosavins and 1% salidroside, third-party verified by NSF International or USP.

What the Evidence Does Not Cover

No registered clinical trial has directly studied the combination of rhodiola rosea and testosterone gel in hypogonadal men as of January 2025. The interaction guidance in this article is derived from:

1. Pharmacokinetic data on testosterone gel (from FDA labeling and PK studies) [1, 2]
2. In vitro and human PK studies on rhodiola's CYP and transporter effects [10, 11]
3. Clinical trial data on rhodiola's pharmacodynamic profile [7, 8, 9, 13]
4. Mechanistic literature on rhodiola's MAOI activity [5]
5. Endocrine Society guideline monitoring recommendations [3]

The absence of a direct interaction trial means uncertainty exists. That uncertainty favors disclosure to your prescriber and conservative dosing, not avoidance of the combination in all cases.

Rhodiola and Testosterone: Is There a Direct Hormonal Effect?

Some men take rhodiola hoping it will raise testosterone levels. The evidence is modest and mostly animal-based. A 2009 study in the Bulletin of Experimental Biology and Medicine found that salidroside increased serum testosterone in stressed male rats by reducing corticosterone (the rat equivalent of cortisol) [18]. Human trials have not replicated a consistent testosterone-raising effect in men.

A small pilot study (N=26 men) published in the Journal of the International Society of Sports Nutrition tested rhodiola supplementation at 600 mg/day for 4 weeks in recreational athletes and found no statistically significant change in serum testosterone compared to placebo [19]. Men on AndroGel should not expect rhodiola to amplify their testosterone levels. The HPG axis is suppressed by exogenous testosterone regardless, so the cortisol-mediated pathway theorized in animal models is not active in this population [3].

AndroGel Application Best Practices When Using Supplements

Transdermal testosterone delivery depends on skin absorption. Any topical substance applied to the same skin area as AndroGel can theoretically alter absorption. This is not specific to rhodiola (which is an oral supplement) but is worth noting for the broader supplement-and-gel user.

Apply AndroGel to clean, dry skin on the shoulders, upper arms, or abdomen per the prescribing information [1]. Wait at least 5 hours before swimming or showering. Avoid applying sunscreen, lotions, or other topicals to the application site for at least 2 hours post-application. These steps have no interaction with oral rhodiola but matter for maintaining stable serum testosterone levels overall.

Key Takeaways for Clinicians

The Natural Medicines Database classifies the rhodiola-MAOI combination as a "moderate" interaction based on mechanistic plausibility [5]. For rhodiola combined with testosterone therapy specifically, no severity rating beyond "theoretical" applies given the absence of direct trial data. Clinicians reviewing a patient on AndroGel who requests rhodiola should:

• Screen for co-prescribed serotonergic, noradrenergic, or stimulant medications before approving the combination
• Confirm baseline blood pressure and heart rate
• Schedule a testosterone recheck at 4 to 6 weeks per standard Endocrine Society monitoring [3]
• Advise the patient to choose a standardized, third-party-tested product [17]
• Document the supplement in the medication list to enable future interaction screening

The 2018 Endocrine Society guideline notes: "We suggest prescribers discuss the potential harms and benefits of testosterone therapy and establish treatment goals before initiating therapy" [3]. That shared decision-making process is the right framework for supplement additions as well.